Is DSIP different from melatonin?

Yes — mechanistically distinct and complementary. Melatonin regulates circadian timing, signaling nighttime and shifting sleep onset. DSIP promotes delta sleep architecture within a sleep session, without circadian effects. Melatonin tells your body when to sleep; DSIP influences the quality (specifically slow-wave depth) of the sleep itself. They work on different aspects of sleep and are not redundant.

Does DSIP help with opiate withdrawal?

Multiple human studies from the 1980s–1990s showed DSIP significantly reduces opiate withdrawal symptoms — craving, anxiety, autonomic symptoms, and sleep disruption. The mechanism is not fully characterized but likely involves normalization of stress hormone patterns and sleep architecture that are severely disrupted during opiate withdrawal. These findings have been replicated in multiple studies.

What is the Semax Selank DSIP sleep stack?

The DSIP + Selank + Semax sleep-cognition stack: DSIP (100–200 mcg SC before bed) for slow-wave sleep promotion; Selank (250 mcg intranasal before bed) for pre-sleep anxiety reduction and sleep quality; Semax (100 mcg intranasal upon waking) for next-day cognitive clarity and BDNF. Each compound addresses a different aspect of the sleep-cognition relationship — architecture quality, anxiety reduction, and next-day performance.

COMPOUND LIBRARY·DSIP

COMPOUND PROFILE · PEPPERLEDGER

DSIP (Delta Sleep-Inducing Peptide)

Isolated 1974 · Marcel Monnier · University of Basel

Type

Endogenous nonapeptide — Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu — naturally present in hypothalamus, limbic system, pituitary

Class

Sleep-modulating neuropeptide · Stress hormone modulator · GH secretagogue (weak) · Antioxidant

Administration

Subcutaneous or IV injection · Intranasal (investigated)

Half-life

~30–40 minutes in plasma; effects on sleep architecture persist hours beyond clearance

Most studied use

Sleep quality improvement · Stress resilience · GH pulse enhancement · Opiate withdrawal support

Regulatory status

Not FDA-approved · Not WADA-banned · Research chemical · Studied in humans since the 1970s

Human evidence

Moderate — multiple human studies from 1970s–2000s showing sleep architecture effects, stress modulation, and GH enhancement; no recent large RCTs

Preclinical evidence

Strong — well-characterized sleep, stress, and metabolic effects across multiple animal models

EDUCATIONAL TOOL — NOT MEDICAL ADVICE

What is DSIP?

DSIP (Delta Sleep-Inducing Peptide) is one of the oldest neuropeptides in the biohacker toolkit — isolated in 1974 from rabbit thalamus by Marcel Monnier's group at the University of Basel, characterized as a 9-amino-acid peptide that, when transferred via blood from a sleeping rabbit to an awake rabbit, induced delta-wave sleep. This cross-circulation experiment was striking: a peptide produced during sleep that, when transferred systemically, induced sleep in another animal. Fifty years of subsequent research has largely confirmed DSIP's sleep-modulating role while revealing a much broader set of biological activities.

DSIP is not a sedative in the conventional sense — it doesn't produce the pharmacological sleep induction of benzodiazepines or z-drugs. Instead, it appears to modulate sleep architecture, promoting the transition into and maintenance of delta (slow-wave, deep) sleep. This is the stage of sleep associated with GH secretion, memory consolidation, physical recovery, and immune function. For biohackers focused on sleep quality rather than just duration, DSIP's mechanism is specifically interesting: not more sleep, but better sleep architecture.

Beyond sleep, DSIP has documented effects on: stress hormone modulation (reduces corticosterone in stress models), GH pulse enhancement (timing synergistic with the GH-sleep relationship), antioxidant protection, and opiate withdrawal management (multiple human studies showing DSIP reduces withdrawal symptoms). The evidence base is older and thinner than for newer compounds — most human studies were conducted in the 1970s–1990s. The compound has a clean safety profile across that research history.

How it works

Delta Sleep Architecture Modulation

DSIP promotes delta (slow-wave) sleep — the deepest stage of non-REM sleep characterized by 0.5–4 Hz brain waves. The mechanism is not fully characterized: DSIP receptors have not been definitively cloned and the peptide's binding sites and downstream signaling remain active research questions. What is established: IV DSIP in humans increases time in slow-wave sleep, reduces sleep fragmentation, and improves subjective sleep quality. The effects persist beyond the peptide's plasma half-life, suggesting downstream signaling that outlasts DSIP's presence.

Stress Hormone Modulation and GH Enhancement

DSIP reduces excessive HPA axis reactivity — it lowers elevated corticosterone in stress models and normalizes LH pulsatility disrupted by stress. This stress adaptation role may be related to delta sleep's function as a restorative state. DSIP also enhances GH secretion, particularly the GH pulses that occur during slow-wave sleep — both through weak GHSR interaction and indirectly via improved delta sleep itself. For users running GH secretagogue protocols, DSIP's timing with the GH-sleep pulse is mechanistically complementary.

What the research shows

HUMAN EVIDENCE

STUDYInternational Journal of Clinical Pharmacology · 1981

DSIP improves sleep measures in a controlled human trial

Schneider-Helmert D, Gnirss F, Monnier M et al.

Double-blind crossover trial in which intravenous DSIP increased total sleep (~59% more in the interval after dosing) and shortened sleep-onset latency on later nights, improving sleep efficiency — notably without classic sedation, suggesting DSIP supports natural sleep rather than knocking you out. An early, methodologically careful human DSIP sleep study.

View on PubMed →

STUDYNeuropsychobiology · 1983

DSIP relieves alcohol and opiate withdrawal symptoms — clinical study

Dick P et al.

67 patients in acute withdrawal (28 from alcohol, 39 from opiates) given intravenous DSIP. Of 49 evaluable patients, 48 improved — rapid, lasting relief of somatic withdrawal signs, with anxiety resolving over hours and no major side effects. Early clinical signal for DSIP's proposed opiate-receptor activity in withdrawal.

View on PubMed →

WHAT THE RESEARCH SHOWS

✓KNOWN

✓Slow-wave sleep increase in human insomnia trials — multiple controlled studies
✓Opiate withdrawal symptom reduction — replicated in multiple human studies
✓Stress hormone normalization in animal and human models
✓GH pulse enhancement during sleep — direct and indirect mechanisms
✓Clean 50-year safety record across research use — no serious adverse events

?UNCERTAIN

?DSIP receptor identity and downstream signaling — not definitively characterized
?Optimal dose and route for sleep vs. other applications
?Long-term safety with repeated use
?Modern large RCT data — most studies are older and smaller by current standards
?Whether antioxidant effects occur at human doses

What the community reports

—Deeper, more restorative sleep — the most commonly reported effect; described as feeling genuinely rested rather than just having slept longer

—Vivid dreams — consistent with increased slow-wave and REM sleep architecture

—Stress resilience improvement — reduced cortisol-adjacent effects during high-stress periods

—The sleep stack: DSIP + Selank (anxiety, sleep quality) + Semax (next-day cognitive performance) — addressing different aspects of the sleep-cognition relationship

—On-demand use is the dominant pattern — before sleep during high-stress periods, not daily continuous use

Common misconceptions

"DSIP works like a sleeping pill."

REALITY

DSIP doesn't produce pharmacological sedation like benzodiazepines or z-drugs. It modulates sleep architecture — specifically promoting slow-wave (delta) sleep. Users who expect to feel knocked out are often underwhelmed. Users who track sleep quality (deeper sleep, fewer wakings, morning restoration) notice the effects more clearly.

"DSIP is the same as melatonin."

REALITY

Melatonin regulates circadian timing — it signals nighttime and helps shift sleep onset. DSIP promotes delta sleep architecture within a sleep session. They work on different aspects of sleep and are mechanistically complementary rather than redundant.

"The research is too old to be relevant."

REALITY

DSIP was isolated in 1974 and most human trials were conducted in the 1970s–1990s. The core findings have been consistent across decades of smaller studies. Age of research doesn't invalidate findings — it just means large-scale modern RCT data hasn't been generated.

SLEEP STACK

DSIP (slow-wave sleep architecture) pairs with Selank (pre-sleep anxiety reduction, GABA-A modulation) and Semax (next-day cognitive clarity and BDNF upon waking). Each compound addresses a different aspect of the sleep-cognition cycle.

RECONSTITUTION CALCULATOR

Peptide in vial (mg)BAC water (mL)Desired dose (mcg)

EDUCATIONAL TOOL — NOT MEDICAL ADVICE · VERIFY WITH YOUR CLINICIAN

AI RESEARCHER PREVIEW

I want to improve my slow-wave sleep quality. How should I use DSIP and what else should I stack it with?

DSIP is specifically designed for the slow-wave sleep problem — it modulates sleep architecture rather than inducing sedation. Here's how to use it effectively. Protocol: 100–200 mcg subcutaneous, 30–60 minutes before your intended sleep time. Start at 100 mcg for the first 2–3 uses to establish your response before moving to 200 mcg. The timing matters — 30–60 minutes gives the peptide time to reach CNS targets before sleep onset. Frequency: on-demand or 3–5 nights per week during periods of poor sleep or high stress. The community converges on situational rather than nightly use — DSIP is most valuable when you specifically need sleep quality restoration. What to track: morning restoration rating (how rested you feel) and dream recall (a reliable proxy for delta and REM sleep quality). If you're using a wearable that tracks sleep stages, that gives you more objective data on whether slow-wave sleep is increasing. The DSIP + Selank + Semax stack is the canonical approach if sleep quality is genuinely the goal: DSIP 100–200 mcg SC 30–60 min before bed (slow-wave architecture), Selank 250 mcg intranasal before bed (reduces the pre-sleep anxiety that fragments sleep onset), Semax 100 mcg intranasal upon waking (cognitive clarity and BDNF for next-day performance). This three-compound approach addresses different rate-limiters of sleep quality simultaneously. If you're also running a GH secretagogue (sermorelin, ipamorelin), DSIP is specifically complementary — DSIP promotes the delta sleep during which GH secretion peaks, while the secretagogue amplifies the GH pulse. Injecting both 30–60 minutes before bed covers both aspects. What's primarily limiting your sleep — is it getting to sleep, staying asleep, or waking unrefreshed despite adequate duration?

CONTINUE IN THE APP

Open PepperLedger to track your DSIP protocol →

Free to join. No credit card. Ask the Researcher about your sleep protocol once you're in.

Free to join · No credit card · 23-day Pro trial included